Literature DB >> 19039651

Peroxisome proliferator-activated receptor-alpha modulates insulin gene transcription factors and inflammation in adipose tissues in mice.

Akadiri Yessoufou1, Jean-Marc Atègbo, Eugène Attakpa, Aziz Hichami, Kabirou Moutairou, Karim L Dramane, Naim A Khan.   

Abstract

We have recently reported that PPAR alpha deficiency leads to hypoglycaemia and hypoinsulinemia in mice (Yessoufou et al. Endocrinology 147:4410-4418, 2006). Besides, these mice exhibited high adiposity with an inflammatory state. We, therefore, assessed, in this study, the effects of PPAR alpha deficiency on the expression of mRNA encoding for the insulin gene transcription factors in pancreatic beta-cells along with those implicated in inflammation in adipose tissues. On fasting, the adult PPAR alpha-null mice were hypoglycemic. Serum insulin concentrations and its pancreatic mRNA transcripts were downregulated in PPAR alpha-null mice, suggesting that PPAR alpha gene deletion contributes to low insulin gene transcription. The PPAR alpha gene deletion downregulates the mRNA expression of insulin gene transcription factors, i.e., Pdx-1, Nkx6.1, and MafA. Besides, the pancreatic function was diminished by PPAR alpha deficiency as PPAR alpha-null mice expressed low pancreatic Glut2 and glucokinase mRNA. PPAR alpha-null mice also expressed high adiponectin and leptin mRNA levels compared to wild type animals. Adipose tissues of PPAR alpha-null mice exhibited upregulation of CD14 and CD68 mRNA, generally expressed by macrophages. PPAR alpha gene deletion downregulates the adipocyte mRNA of certain pro-inflammatory agents, like MCP-1, TNF-alpha, IL-1 beta, IL-6, and RANTES, though pro-inflammatory TLR-2 and TLR-4 mRNAs were upregulated in the adipose tissues. Our results suggest that PPAR alpha deficiency, in mice, is implicated in the modulation of insulin gene transcription and inflammatory status in adipose tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19039651     DOI: 10.1007/s11010-008-9968-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  51 in total

1.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

2.  ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter.

Authors:  Michael C Lawrence; Kathleen McGlynn; Byung-Hyun Park; Melanie H Cobb
Journal:  J Biol Chem       Date:  2005-05-16       Impact factor: 5.157

3.  Stimulation of insulin secretion by noncarbohydrate metabolites.

Authors:  W J Malaisse; F Malaisse-Lagae
Journal:  J Lab Clin Med       Date:  1968-09

Review 4.  Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.

Authors:  Alberto Zambon; Philippe Gervois; Paolo Pauletto; Jean-Charles Fruchart; Bart Staels
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-19       Impact factor: 8.311

5.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

6.  Leptin-dependent toll-like receptor expression and responsiveness in preadipocytes and adipocytes.

Authors:  Arvind Batra; Jeannette Pietsch; Inka Fedke; Rainer Glauben; Besir Okur; Thorsten Stroh; Martin Zeitz; Britta Siegmund
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

7.  Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.

Authors:  Y P Zhou; V E Grill
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

8.  beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes.

Authors:  U Ahlgren; J Jonsson; L Jonsson; K Simu; H Edlund
Journal:  Genes Dev       Date:  1998-06-15       Impact factor: 11.361

9.  Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.

Authors:  B Staels; N Vu-Dac; V A Kosykh; R Saladin; J C Fruchart; J Dallongeville; J Auwerx
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas.

Authors:  M Sander; L Sussel; J Conners; D Scheel; J Kalamaras; F Dela Cruz; V Schwitzgebel; A Hayes-Jordan; M German
Journal:  Development       Date:  2000-12       Impact factor: 6.868

View more
  11 in total

1.  AMPK enhances the expression of pancreatic duodenal homeobox-1 via PPARalpha, but not PPARgamma, in rat insulinoma cell line INS-1.

Authors:  Hua Guo; Shui Sun; Xu Zhang; Xiu-juan Zhang; Ling Gao; Jia-jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

2.  Regulation of growth performance and lipid metabolism in juvenile grass carp (Ctenopharyngodon idella) with honeysuckle (Lonicera japonica) extract.

Authors:  Xiao-Lin Meng; Zhen-Xiang Zhu; Rong-Hua Lu; Shuai Li; Wen-Pan Hu; Chao-Bin Qin; Xiao Yan; Guo-Kun Yang; Guo-Xing Nie
Journal:  Fish Physiol Biochem       Date:  2019-05-18       Impact factor: 2.794

3.  In vitro exposure to copper influences lipid metabolism in hepatocytes from grass carp (Ctenopharyngodon idellus).

Authors:  Qing-Ling Zhu; Zhi Luo; Mei-Qin Zhuo; Xiao-Ying Tan; Lin-Dan Sun; Jia-Lang Zheng; Qi-Liang Chen
Journal:  Fish Physiol Biochem       Date:  2014-04       Impact factor: 2.794

4.  Opposing actions of Per1 and Cry2 in the regulation of Per1 target gene expression in the liver and kidney.

Authors:  Jacob Richards; Sean All; George Skopis; Kit-Yan Cheng; Brandy Compton; Nitya Srialluri; Lisa Stow; Lauren A Jeffers; Michelle L Gumz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-03       Impact factor: 3.619

Review 5.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

Review 6.  Transcriptional regulation of glucose sensors in pancreatic β-cells and liver: an update.

Authors:  Jin-Sik Bae; Tae-Hyun Kim; Mi-Young Kim; Joo-Man Park; Yong-Ho Ahn
Journal:  Sensors (Basel)       Date:  2010-05-19       Impact factor: 3.576

7.  Using a large-scale knowledge database on reactions and regulations to propose key upstream regulators of various sets of molecules participating in cell metabolism.

Authors:  Pierre Blavy; Florence Gondret; Sandrine Lagarrigue; Jaap van Milgen; Anne Siegel
Journal:  BMC Syst Biol       Date:  2014-03-17

8.  DHA induces apoptosis of human malignant breast cancer tissues by the TLR-4/PPAR-α pathways.

Authors:  Lijing Geng; Wei Zhou; Bing Liu; Xinyun Wang; Bo Chen
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

9.  Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus.

Authors:  Zakir Hossain; Guru R Valicherla; Anand P Gupta; Anees A Syed; Mohammed Riyazuddin; Sharat Chandra; Mohammad I Siddiqi; Jiaur R Gayen
Journal:  Sci Rep       Date:  2018-06-07       Impact factor: 4.379

10.  Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis.

Authors:  Emerson de Andrade Lima; Mariana Modesto Dantas de Andrade Lima; Cláudia Diniz Lopes Marques; Angela Luzia Branco Pinto Duarte; Ivan da Rocha Pita; Maira Galdino da Rocha Pita
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.